Sign in
Taking people in United StatesPhase 4

Comparing Two Steroid Doses Injected Into the Knee for Arthritis in Obese Adults

Tests a low steroid dose against a standard dose injected into the knee for arthritis.

Key facts

Who runs it
Mayo Clinic
Where
Jacksonville, United StatesSee the site
Trial code
Registry title
Knee Injections for Obese Patients With Knee Arthritis
Status
Recruiting
Phase
Phase 4
People taking part
40 people, planned
Started
24 Jan 2025
Expected to end
24 Jan 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Triamcinolone Acetonide Low Dose
  • Triamcinolone Acetonide Standard Dose
Record updated
10 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 55 to 85 with obesity and knee osteoarthritis confirmed on X-ray who want a steroid knee injection. It compares a low dose with a standard dose.

Age
55 to 85 years
Sex
All sexes can join.
Disease stage
Knee osteoarthritis (knee arthritis) proven on X-ray, with BMI of 30 kg/m2 or higher.
Earlier treatment
People cannot have other treatment during the study or be in physical therapy at the time of the study.

Main reasons for not taking part

  • BMI below 30 kg/m2
  • Uncontrolled diabetes with a hemoglobin A1c above 8% (64 mmol/mol)
  • Any other treatment during the study
  • Physical therapy at the time of the study

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patients with BMI ≥30 kg/m2 and radiograph-proven knee osteoarthritis who are interested in receiving a steroid injection for knee arthritis

Who cannot take part

  • Patients that are undergoing physical therapy at the time of the study
  • Uncontrolled diabetics with a hemoglobin A1c > 8%
  • BMI < 30 kg/m2
  • No other treatment within the time frame of the study

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 55 and 85 years old?

Where in United States

  • Mayo Clinic in FloridaJacksonville, United StatesContact: Jeffrey P Nadwodny, DOTaking people

About the trial

What the trial wants to find out

The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.

The 2 groups in the trial

  • Standard Dose GroupExisting treatment, for comparison

    Patients with knee osteoarthritis who are interested in knee intra-articular corticosteroid injections and meet the inclusion criteria.

    Treatment: Triamcinolone Acetonide Standard Dose

  • Lower Dose GroupTreatment being tested

    Patients with knee osteoarthritis who are interested in knee intra-articular corticosteroid injections and meet the inclusion criteria.

    Treatment: Triamcinolone Acetonide Low Dose

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Comparison of Varying Doses of Steroid for Intra-articular Knee Injections
Plain-language title
Comparing Two Steroid Doses Injected Into the Knee for Arthritis in Obese AdultsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06782529, who can take part
Record updated
10 March 2026